Vérification…
Traduit automatiquement. Doses et mises en garde : vérifiez l'original en anglais. Lire en anglais
Accueil / Enregistré au Nigeria / Ciprocet Eye & Ear Drops

Ciprocet Eye & Ear Drops

NAFDAC REG NO: A4-0290 Médicament

Enregistré auprès de NAFDAC. Enregistrement actifAs of 3 November 2026 · synced automatically from official sources.
Produit
Ciprocet Eye & Ear Drops
Numéro NAFDAC
A4-0290
Principe actif
Ciprofloxacin (Ciprofloxacin Hydrochloride)
Dosage
0.3%
Forme
Ear/eye drops
Conditionnement
1 x 5 mL (in PET bottle)
Fabricant
Non répertorié
Déposant / Titulaire :
Merit Healthcare Limited
Approuvé
28 Mar 2023
Statut
Actif Vue sur NAFDAC ↗
Enregistrement valable jusqu'au
27 Mar 2028
Alertes OMS
Non trouvé
Community reports
None
Times checked
0

About the medicine: Ciprofloxacin: uses, dosage and brands worldwide

What we found

  • Ciprocet Eye & Ear Drops is on the NAFDAC register with an active registration (A4-0290). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

How to use Ciprocet Eye & Ear Drops

Ce que dit la notice officielle. Si un médecin vous l'a prescrit, suivez l'ordonnance. La notice de votre boîte prime si elle est différente.

Pour qui

Ciprofloxacin Ophthalmic Solution is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below: Corneal Ulcers: Pseudomonas aeruginosa Serratia marcescens * Staphylococcus aureus Staphylococcus epidermidis Streptococcus pneumoniae Streptococcus (Viridans Group) * Conjunctivitis: Haemophilus influenzae Staphylococcus aureus Staphylococcus epidermidis Streptococcus pneumoniae *Efficacy for this organism was studied in fewer than 10 infections.

Comment le prendre et à quelle fréquence
  • Corneal Ulcers: The recommended dosage regimen
  • For the treatment of corneal ulcers is two drops into the affected eye every 15 minutes for the first six hours and then two drops into the affected eye every 30 minutes for the remainder of the first day
  • On the second day, instill two drops in the affected eye hourly
  • On the third through the fourteenth day, place two drops in the affected eye every four hours
  • Treatment may be continued after 14 days if corneal re-epithelialisation has not occurred
  • Bacterial Conjunctivitis: The recommended dosage regimen
  • For the treatment of bacterial conjunctivitis is one or two drops instilled into the conjunctival sac(s) every two hours while awake for two days and one or two drops every four hours while awake for the next five days
Children
  • The safety and effectiveness of Ciprofloxacin ophthalmic solution 0.3% have been established in all ages
  • Use of Ciprofloxacin ophthalmic solution is supported by evidence from adequate and well controlled studies of Ciprofloxacin ophthalmic solution
  • In adults, children and neonates [ see Clinical Studies ]. …
Older adults

No overall differences in safety or effectiveness have been observed between elderly and younger patients.

While you are taking it

Do not touch dropper tip to any surface, as this may contaminate the solution.

Talk to a doctor first if
  • A history of hypersensitivity to ciprofloxacin or any other component of the medication is a contraindication to its use
  • A history of hypersensitivity to other quinolones may also contraindicate the use of ciprofloxacin
Medicines it may not mix with

Specific drug interaction studies have not been conducted with ophthalmic ciprofloxacin. However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, enhance the effects of the oral anticoagulant, warfarin, and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.

Warnings

NOT FOR INJECTION INTO THE EYE. Serious and occasionally fatal hypersensitivity (anaphylactic) reactions, some following the first dose, have been reported in patients receiving systemic quinolone therapy. Some reactions were accompanied by cardiovascular collapse, loss of consciousness, tingling, pharyngeal or facial edema, dyspnea, urticaria, and itching. Only a few patients had a history of hypersensitivity reactions. Serious anaphylactic reactions require immediate emergency treatment with epinephrine and other resuscitation measures, including oxygen, intravenous fluids, intravenous antihistamines, corticosteroids, pressor amines and airway management, as clinically indicated. …

Effets secondaires possibles

The most frequently reported drug related adverse reaction was local burning or discomfort. In corneal ulcer studies with frequent administration of the drug, white crystalline precipitates were seen in approximately 17% of patients ( see Precautions ). Other reactions occurring in less than 10% of patients included lid margin crusting, crystals/scales, foreign body sensation, itching, conjunctival hyperemia and a bad taste following instillation. Additional events occurring in less than 1% of patients included corneal staining, keratopathy/keratitis, allergic reactions, lid edema, tearing, photophobia, corneal infiltrates, nausea and decreased vision. …

If you take too much

A topical overdose of ciprofloxacin Ophthalmic Solution may be flushed from the eye(s) with warm tap water.

En cas d'oubli

Prenez-le dès que vous y pensez, sauf s'il est presque l'heure de la dose suivante. Dans ce cas, sautez la dose oubliée. Ne prenez jamais deux doses à la fois pour compenser. Vérifiez votre notice, certains médicaments font exception.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2022-05-02.

Label for ciprofloxacin (ciprofloxacin hydrochloride), the active ingredient registered with NAFDAC.

Check your pack of Ciprocet Eye & Ear Drops

Add the expiry date on your pack for a full Trust Score.

Ou prenez la boîte en photo
Encore 3 vérifications gratuites aujourd'hui Official sources: U.S. FDA · EMA (EU) · Health Canada · WHO alerts

About Ciprocet Eye & Ear Drops

What is in Ciprocet Eye & Ear Drops?

Ciprocet Eye & Ear Drops contains Ciprofloxacin (Ciprofloxacin Hydrochloride) (0.3%), as ear/eye drops, according to its NAFDAC registration record.

Is Ciprocet Eye & Ear Drops registered with NAFDAC?

Yes. Ciprocet Eye & Ear Drops is listed on the NAFDAC register under registration number A4-0290, and its registration is active as of 3 November 2026.

Has Ciprocet Eye & Ear Drops been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Ciprocet Eye & Ear Drops in our automatically synced alert list.

How can I check that my pack of Ciprocet Eye & Ear Drops is genuine?

Run a free authenticity scan with the NAFDAC number A4-0290, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Ciprocet Eye & Ear Drops?

Follow your prescription or the leaflet in your pack. The official label says: Corneal Ulcers: The recommended dosage regimen for the treatment of corneal ulcers is two drops into the affected eye every 15 minutes for the first six hours and then two drops into the affected eye every 30 minutes for the remainder of the first day. On the second day, instill two drops in the affected eye hourly. On the third through the fourteenth day, place two drops in th…

What is Ciprocet Eye & Ear Drops used for?

Ciprofloxacin Ophthalmic Solution is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below: Corneal Ulcers: Pseudomonas aeruginosa Serratia marcescens * Staphylococcus aureus Staphylococcus epidermidis Streptococcus pneumoniae Streptococcus (Viridans Group) * Conjunctivitis: Haemophilus influenzae Staphylococcus aure (Summarised from the official U.S. FDA label for ciprofloxacin (ciprofloxacin hydrochloride). Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Ciprocet Eye & Ear Drops? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.